Literature DB >> 11292697

Gamma interferon and lipopolysaccharide interact at the level of transcription to induce tumor necrosis factor alpha expression.

J Y Lee1, K E Sullivan.   

Abstract

Lipopolysaccharide (LPS) is a very potent inducer of tumor necrosis factor alpha (TNF-alpha) expression from monocytes and macrophages. Another inflammatory cytokine, gamma interferon (IFN-gamma), can potentiate the effects of LPS, but the mechanism is not thoroughly understood. Previous reports emphasized the ability of IFN-gamma to upregulate CD14 expression (the receptor for LPS), and nearly all studies have utilized sequential stimulation with IFN-gamma followed by LPS to exploit this phenomenon. This study demonstrates that IFN-gamma can upregulate the effect of LPS at the level of transcription. Human monoblastic Mono-Mac-6 cells produced up to threefold-greater levels of TNF-alpha when simultaneously stimulated with LPS and IFN-gamma compared to treatment with LPS alone. RNase protection studies showed a similar increase in RNA beginning as early as within 30 min. The synthesis of TNF-alpha mRNA in IFN-gamma- and LPS-treated Mono-Mac-6 cells was also temporally prolonged even though the message turnover rate was identical to that seen in LPS stimulated cells. The modulatory effect of IFN-gamma may be mediated by Jak2.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11292697      PMCID: PMC98233          DOI: 10.1128/IAI.69.5.2847-2852.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  55 in total

Review 1.  Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases.

Authors:  P J Barnes; M Karin
Journal:  N Engl J Med       Date:  1997-04-10       Impact factor: 91.245

Review 2.  Protein modules and signalling networks.

Authors:  T Pawson
Journal:  Nature       Date:  1995-02-16       Impact factor: 49.962

Review 3.  Cellular responses to interferon-gamma.

Authors:  U Boehm; T Klamp; M Groot; J C Howard
Journal:  Annu Rev Immunol       Date:  1997       Impact factor: 28.527

4.  Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein.

Authors:  L W Moreland; S W Baumgartner; M H Schiff; E A Tindall; R M Fleischmann; A L Weaver; R E Ettlinger; S Cohen; W J Koopman; K Mohler; M B Widmer; C M Blosch
Journal:  N Engl J Med       Date:  1997-07-17       Impact factor: 91.245

Review 5.  Tyrosine kinase inhibition: an approach to drug development.

Authors:  A Levitzki; A Gazit
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

Review 6.  GAS elements: a few nucleotides with a major impact on cytokine-induced gene expression.

Authors:  T Decker; P Kovarik; A Meinke
Journal:  J Interferon Cytokine Res       Date:  1997-03       Impact factor: 2.607

7.  Lipopolysaccharide-induced expression of TNF-alpha gene in the macrophage cell line ANA-1 is regulated at the level of transcription processivity.

Authors:  A Biragyn; S A Nedospasov
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

8.  Transcriptional activation of the human TNF-alpha promoter by superantigen in human monocytic cells: role of NF-kappa B.

Authors:  N S Trede; A V Tsytsykova; T Chatila; A E Goldfeld; R S Geha
Journal:  J Immunol       Date:  1995-07-15       Impact factor: 5.422

9.  Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice.

Authors:  S Georgopoulos; D Plows; G Kollias
Journal:  J Inflamm       Date:  1996

10.  Activation of Raf-1 and mitogen-activated protein kinase in murine macrophages partially mimics lipopolysaccharide-induced signaling events.

Authors:  J Hambleton; M McMahon; A L DeFranco
Journal:  J Exp Med       Date:  1995-07-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Regulation of inflammation.

Authors:  Kathleen E Sullivan
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

Review 2.  Immune senescence, epigenetics and autoimmunity.

Authors:  Donna Ray; Raymond Yung
Journal:  Clin Immunol       Date:  2018-04-11       Impact factor: 3.969

3.  Noncoding RNAs and LRRFIP1 regulate TNF expression.

Authors:  Lihua Shi; Li Song; Michael Fitzgerald; Kelly Maurer; Asen Bagashev; Kathleen E Sullivan
Journal:  J Immunol       Date:  2014-02-24       Impact factor: 5.422

4.  JAK2 inhibition prevents innate immune responses and rescues animals from sepsis.

Authors:  Geber Peña; Bolin Cai; Edwin A Deitch; Luis Ulloa
Journal:  J Mol Med (Berl)       Date:  2010-08       Impact factor: 4.599

5.  The underdeveloped innate immunity in embryonic stem cells: The molecular basis and biological perspectives from early embryogenesis.

Authors:  Yan-Lin Guo
Journal:  Am J Reprod Immunol       Date:  2019-01-28       Impact factor: 3.886

6.  Tumor necrosis factor-a augments lipopolysaccharide-induced suppressor of cytokine signalling 3 (SOCS-3) protein expression by preventing the degradation.

Authors:  Jargalsaikhan Dagvadorj; Yoshikazu Naiki; Gantsetseg Tumurkhuu; Abu Shadat Mohammod Noman; Imtiaz Iftakhar-E-Khuda; Takayuki Komatsu; Naoki Koide; Tomoaki Yoshida
Journal:  Immunology       Date:  2010-01       Impact factor: 7.397

7.  Neutralization of TNFalpha alters inflammation in guinea pig tuberculous pleuritis.

Authors:  Lan H Ly; Amminikutty Jeevan; David N McMurray
Journal:  Microbes Infect       Date:  2009-04-21       Impact factor: 2.700

8.  Kinetics of a gamma interferon response: expression and assembly of CIITA promoter IV and inhibition by methylation.

Authors:  Ann C Morris; Guy W Beresford; Myesha R Mooney; Jeremy M Boss
Journal:  Mol Cell Biol       Date:  2002-07       Impact factor: 4.272

9.  Epigenetic regulation of tumor necrosis factor alpha.

Authors:  K E Sullivan; A B M Reddy; K Dietzmann; A R Suriano; V P Kocieda; M Stewart; M Bhatia
Journal:  Mol Cell Biol       Date:  2007-05-21       Impact factor: 4.272

10.  Anti-inflammation of spirocyclopiperazinium salt compound LXM-10 targeting α7 nAChR and M4 mAChR and inhibiting JAK2/STAT3 pathway in rats.

Authors:  Weiwei Zhang; Qi Sun; Xiaoli Gao; Yimin Jiang; Runtao Li; Jia Ye
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.